SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for LFST.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
March 31, 2026 100.33M
December 31, 2025 94.78M
September 30, 2025 95.62M
June 30, 2025 97.38M
March 31, 2025 94.43M
December 31, 2024 93.71M
September 30, 2024 85.27M
June 30, 2024 95.15M
March 31, 2024 88.93M
December 31, 2023 93.37M
September 30, 2023 130.94M
June 30, 2023 101.85M
Date Value
March 31, 2023 84.63M
December 31, 2022 89.82M
September 30, 2022 81.25M
June 30, 2022 103.56M
March 31, 2022 103.37M
December 31, 2021 152.65M
September 30, 2021 162.94M
June 30, 2021 85.48M
March 31, 2021 32.65M
December 31, 2020 0.00
September 30, 2020 19.53M

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Acadia Healthcare Co., Inc. 53.20M
DaVita, Inc. 421.91M
U.S. Physical Therapy, Inc. 18.27M
Progyny, Inc. 47.69M
Tenet Healthcare Corp. 0.00